Development of age spots as a result of accumulation of aged cells in aged skin

Age spots are the brown spots that develop in the skin but change in color and shape with time. To understand the mechanism of development of age spots, characteristics of age spots are analyzed by Misrepair mechanism, a mechanism introduced in Misrepair-accumulation aging theory. An age spot is pathologically a group of aggregated basal cells, which contain lipofuscin bodies. Accumulation of lipofuscin bodies is a sign of aging of a cell. Characteristics of age spots include: inhomogeneity in distribution, growing flatly before becoming protruding, irregularity on shape, inhomogeneity on the color and on the protruding degree of a spot, and softness of a protruding spot. After analyzing these characteristics, we make a hypothesis on the process of development of an age spot. A. Aging of a tissue is the basis for development of age spots. B. A flat spot results from accumulation of lipofuscin containing cells. When an aged cell remains, this cell can accelerate the aging of its neighbor cells by increasing damage sensitivity and reducing repair efficiency of the local tissue. By a viscous circle, more and more neighbor cells become aged and they form a flat spot, which has an irregular shape. C. A protruding spot develops when some of the cells in a flat spot die and release lipofuscin bodies. For the survival of an organism, the un degradable lipofuscin bodies have to be isolated by a capsule made by fibrotic membrane, for maintaining the structural integrity of local epidermis. Successive deaths of lipofuscin containing cells make the capsule include more and more dead substances by layers of fibrotic membrane. In this way, the spot “grows” in three-dimension, resulting in protruding of the spot. In conclusion, development of an age spot is a result of accumulation of aged cells in aged skin.

💡 Research Summary

The paper proposes a novel explanation for the formation of age‑related brown spots (age spots) on human skin, grounding the phenomenon in the “Misrepair‑accumulation” theory of aging. According to the authors, an age spot is a localized cluster of basal epidermal cells that have accumulated lipofuscin, an indigestible pigment‑like waste product that serves as a reliable cellular aging marker. The authors first enumerate the clinical hallmarks of age spots: irregular distribution, an initial flat phase that later becomes raised, heterogeneous shape and colour, and a soft consistency of the protruding portion.

From these observations they construct a three‑stage mechanistic hypothesis. Stage 1 posits that aged skin tissue provides the permissive environment for spot initiation. When a single basal cell becomes senescent and retains lipofuscin, it releases senescence‑associated secretory phenotype (SASP) factors that increase the damage sensitivity of neighboring cells and diminish local repair efficiency. This creates a positive feedback loop: adjacent cells also become senescent, accumulate lipofuscin, and join the growing flat patch. The irregular geometry of the spot reflects the stochastic spread of this senescent “cloud.”

Stage 2 addresses the transition from a flat to a raised lesion. As some lipofuscin‑laden cells die, they release their indigestible contents into the extracellular space. The organism, unable to degrade lipofuscin, isolates it by surrounding the debris with a fibrotic capsule composed mainly of collagen and other extracellular‑matrix proteins. This encapsulation is analogous to a wound‑healing fibrotic response and serves to preserve epidermal integrity while sequestering toxic material.

Stage 3 explains the three‑dimensional growth of the spot. Repeated cycles of cell death and capsule formation add successive layers of fibrotic membrane around the accumulating lipofuscin core. Each new layer pushes the lesion outward, producing the characteristic protrusion and soft texture observed clinically. The colour variation of the raised spot correlates with the density of lipofuscin and the thickness of the fibrotic envelope.

The authors conclude that age spots are not merely the result of melanin accumulation or UV‑induced damage, but rather a manifestation of tissue‑level misrepair driven by the accumulation of aged cells. This perspective integrates cellular senescence, SASP‑mediated propagation of damage, and fibrotic isolation of undegradable waste into a coherent model.

While conceptually appealing, the manuscript lacks direct experimental evidence. Quantitative measurements of lipofuscin content, SASP factor expression, and fibrotic markers (e.g., α‑SMA, collagen I/III) in flat versus raised spots are absent. Moreover, the proposed feedback loop between senescent cells and neighboring tissue has not been demonstrated in vivo. Future work should therefore include high‑resolution imaging of lipofuscin‑rich cells, longitudinal biopsies tracking spot evolution, and manipulation of key pathways (e.g., TGF‑β signaling, senolytic drugs) to test whether interrupting the misrepair cycle can prevent spot formation or promote regression. Such studies would not only validate the Misrepair‑accumulation hypothesis but also open avenues for therapeutic strategies targeting age‑related skin discoloration.